82 related articles for article (PubMed ID: 20926288)
1. Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer.
Yoshida Y; Kurokawa T; Horiuchi Y; Sawamura Y; Shinagawa A; Kotsuji F
Eur J Cancer; 2010 Dec; 46(18):3445-52. PubMed ID: 20926288
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of phosphorylated mammalian target of rapamycin is associated with poor survival in oesophageal adenocarcinoma: a tissue microarray study.
Prins MJ; Verhage RJ; Ruurda JP; ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2013 Mar; 66(3):224-8. PubMed ID: 23162107
[TBL] [Abstract][Full Text] [Related]
3. The phosphatidylinositol 3' kinase-Akt-mammalian target of rapamycin pathway in smooth muscle tumors of the uterus: selected protein expression patterns and their clinicopathologic implications.
Fadare O; Renshaw I; Olson SJ; Liang SX
Int J Gynecol Pathol; 2011 May; 30(3):244-51. PubMed ID: 21464729
[TBL] [Abstract][Full Text] [Related]
4. The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation.
Ettl T; Schwarz-Furlan S; Haubner F; Müller S; Zenk J; Gosau M; Reichert TE; Zeitler K
Oral Oncol; 2012 Sep; 48(9):822-30. PubMed ID: 22445095
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.
Righi L; Volante M; Rapa I; Tavaglione V; Inzani F; Pelosi G; Papotti M
Endocr Relat Cancer; 2010 Dec; 17(4):977-87. PubMed ID: 20817788
[TBL] [Abstract][Full Text] [Related]
6. Expression of phosphorylated Akt, mTOR and MAPK in type I endometrial carcinoma: clinical significance.
Kourea HP; Nikolaou M; Tzelepi V; Adonakis G; Kardamakis D; Tsapanos V; Scopa CD; Kalofonos C; Decavalas G
Anticancer Res; 2015 Apr; 35(4):2321-31. PubMed ID: 25862896
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of pmTOR expression in endometrioid endometrial carcinoma.
Choi CH; Lee JS; Kim SR; Kim TJ; Lee JW; Kim BG; Bae DS
Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):207-10. PubMed ID: 20727662
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ret finger protein correlates with outcomes in endometrial cancer.
Tsukamoto H; Kato T; Enomoto A; Nakamura N; Shimono Y; Jijiwa M; Asai N; Murakumo Y; Shibata K; Kikkawa F; Takahashi M
Cancer Sci; 2009 Oct; 100(10):1895-901. PubMed ID: 19650860
[TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy.
Faried LS; Faried A; Kanuma T; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Oncol Rep; 2006 Jul; 16(1):57-63. PubMed ID: 16786123
[TBL] [Abstract][Full Text] [Related]
10. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
[TBL] [Abstract][Full Text] [Related]
11. mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.
Kasajima A; Pavel M; Darb-Esfahani S; Noske A; Stenzinger A; Sasano H; Dietel M; Denkert C; Röcken C; Wiedenmann B; Weichert W
Endocr Relat Cancer; 2011 Feb; 18(1):181-92. PubMed ID: 21159731
[TBL] [Abstract][Full Text] [Related]
12. p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
Beca F; Andre R; Martins DS; Bilhim T; Martins D; Schmitt F
J Clin Pathol; 2014 Nov; 67(11):961-7. PubMed ID: 25053543
[TBL] [Abstract][Full Text] [Related]
13. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
14. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
Faried LS; Faried A; Kanuma T; Aoki H; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
17. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
18. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
19. Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases.
Chen TC; Wu CT; Wang CP; Yang TL; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2015 May; 51(5):493-9. PubMed ID: 25769791
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas.
Bakarakos P; Theohari I; Nomikos A; Mylona E; Papadimitriou C; Dimopoulos AM; Nakopoulou L
Histopathology; 2010 Jun; 56(7):876-82. PubMed ID: 20636791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]